tiprankstipranks
Trending News
More News >
CleanSpace Holdings Ltd. (AU:CSX)
ASX:CSX
Australian Market

CleanSpace Holdings Ltd. (CSX) AI Stock Analysis

Compare
6 Followers

Top Page

AU:CSX

CleanSpace Holdings Ltd.

(Sydney:CSX)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 4o)
Rating:43Neutral
Price Target:
AU$0.61
▼(-3.49% Downside)
CleanSpace Holdings Ltd. is currently facing significant financial and technical challenges. The most impactful factors are the ongoing profitability issues and weak cash flow performance, compounded by bearish technical indicators. The negative P/E ratio and lack of dividend yield further detract from the stock's valuation appeal. Overall, the stock's outlook is cautious, with financial instability and negative market momentum being the primary concerns.
Positive Factors
Revenue Growth
The recent improvement in revenue growth indicates that CleanSpace Holdings is successfully expanding its market reach and product adoption, which is a positive sign for long-term business sustainability.
Product Innovation
CleanSpace's focus on innovation in respiratory protection positions it well to maintain a competitive advantage and capture market share in the safety and industrial equipment sector.
Gross Profit Margin
A strong gross profit margin indicates effective cost management, providing CleanSpace with the ability to reinvest in growth initiatives and maintain financial health over the long term.
Negative Factors
Profitability Issues
Ongoing profitability issues suggest operational challenges that could hinder CleanSpace's ability to generate sustainable profits and limit its financial flexibility.
Weak Cash Flow
Weak cash flow performance indicates difficulties in converting income into cash, which could impact CleanSpace's ability to fund operations and invest in growth opportunities.
Negative Return on Equity
A negative return on equity highlights inefficiencies in utilizing shareholder funds, which may deter potential investors and affect long-term financial stability.

CleanSpace Holdings Ltd. (CSX) vs. iShares MSCI Australia ETF (EWA)

CleanSpace Holdings Ltd. Business Overview & Revenue Model

Company DescriptionCleanSpace Holdings Limited engages in the design, manufacture, and sale of respirators and related products and services for healthcare and industrial employers worldwide. It offers CleanSpace HALO, a personal respiratory protection for healthcare; CleanSpace ULTRA, a personal respiratory protection for face/eye protection and water tolerance; CleanSpace2, a personal respiratory protection for workers in general industrial environments; and CleanSpace EX for personal protection for people working in explosive environments. The company also provides accessories and consumable products comprising masks, filters, docking stations, cleaning and storage products, car chargers, biohoods, half mask and bio mask exhalation adaptors, unit id panels, mask id badges, mask decal, helmet hook strap, hoods, backpacks, full face mask quantitative fit test, full face mask spectacle kits, visor protectors, head harness, grommet, and spares. It serves mining, welding, construction, laboratory, dental, wastewater, and healthcare and first responder's industries. CleanSpace Holdings Limited was founded in 2009 and is based in St Leonards, Australia.
How the Company Makes MoneyCleanSpace Holdings generates revenue primarily through the sale of its respiratory protection equipment and accessories. The company has a diversified revenue model that includes direct sales to customers, distribution partnerships, and contracts with government and healthcare institutions. Key revenue streams consist of product sales, recurring sales from replacement parts and filters, and service agreements for maintenance and training on the use of their equipment. Strategic partnerships with distributors and industry leaders further enhance market reach and contribute to earnings, while ongoing investments in research and development help to innovate and expand their product offerings, attracting new customers and retaining existing ones.

CleanSpace Holdings Ltd. Financial Statement Overview

Summary
CleanSpace Holdings Ltd. faces significant financial challenges, with ongoing profitability issues and weak cash flow performance. While revenue growth has shown recent improvement, the company struggles with negative margins and low returns on equity. The balance sheet is moderately leveraged, providing some stability, but overall financial health remains a concern.
Income Statement
45
Neutral
CleanSpace Holdings Ltd. has experienced fluctuating revenue growth, with a recent positive growth rate of 12.25% after a period of decline. However, profitability remains a concern with negative net profit margins and EBIT margins, indicating ongoing operational challenges. The gross profit margin is relatively strong at 74.76%, suggesting effective cost management despite overall losses.
Balance Sheet
55
Neutral
The company's debt-to-equity ratio is moderate at 0.24, indicating a balanced approach to leveraging. However, the return on equity is negative, reflecting the company's struggle to generate profits from shareholders' equity. The equity ratio is not provided, but the overall financial stability is moderate with manageable debt levels.
Cash Flow
40
Negative
Cash flow performance is weak, with a significant decline in free cash flow growth. The operating cash flow to net income ratio is low, indicating challenges in converting income into cash. However, the free cash flow to net income ratio is relatively high, suggesting some efficiency in cash management despite overall cash flow issues.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue19.76M19.76M15.72M12.09M13.36M49.93M
Gross Profit14.78M14.78M11.36M-5.16M9.75M40.27M
EBITDA-824.55K-824.55K-3.49M-10.55M-14.10M17.15M
Net Income-478.28K-478.28K-3.13M-8.13M-11.28M11.39M
Balance Sheet
Total Assets27.57M27.57M26.05M28.98M38.36M50.72M
Cash, Cash Equivalents and Short-Term Investments10.47M10.47M9.76M12.16M24.30M38.24M
Total Debt4.54M4.54M3.45M4.00M4.13M4.38M
Total Liabilities8.41M8.41M6.95M7.02M8.60M9.99M
Stockholders Equity19.16M19.16M19.10M21.96M29.75M40.73M
Cash Flow
Free Cash Flow1.01M1.01M-1.76M-11.97M-13.60M11.73M
Operating Cash Flow1.11M1.11M-1.73M-11.96M-13.00M13.46M
Investing Cash Flow-1.04M-778.38K2.00M7.06M-628.00K-14.18M
Financing Cash Flow-533.88K-559.87K-637.10K-211.49K-357.95K16.19M

CleanSpace Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.63
Price Trends
50DMA
0.68
Negative
100DMA
0.73
Negative
200DMA
0.60
Positive
Market Momentum
MACD
-0.02
Positive
RSI
39.54
Neutral
STOCH
19.44
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CSX, the sentiment is Negative. The current price of 0.63 is below the 20-day moving average (MA) of 0.65, below the 50-day MA of 0.68, and above the 200-day MA of 0.60, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 39.54 is Neutral, neither overbought nor oversold. The STOCH value of 19.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:CSX.

CleanSpace Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
AU$13.43M-1.63-103.74%14.84%39.64%
50
Neutral
AU$70.02M-5.38-31.98%34.20%-23.90%
48
Neutral
$76.40M-74.00%23.31%-17.35%
44
Neutral
AU$171.94M-16.13-70.55%-257.32%
43
Neutral
AU$49.38M-2.50%25.72%84.69%
41
Neutral
AU$60.10M-128.19%-14.25%-22.83%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:CSX
CleanSpace Holdings Ltd.
0.63
0.26
70.27%
AU:IPD
Impedimed Limited
0.04
-0.02
-33.33%
AU:CYC
Cyclopharm Limited
1.00
-0.62
-38.27%
AU:MX1
Micro-X Ltd.
0.09
<0.01
12.50%
AU:EMV
EMvision Medical Devices Ltd.
1.77
-0.06
-3.29%
AU:CBL
Control Bionics Ltd.
0.07
0.01
16.67%

CleanSpace Holdings Ltd. Corporate Events

CleanSpace Holdings Secures Strong Shareholder Support at 2025 AGM
Nov 28, 2025

CleanSpace Holdings Limited announced that all resolutions at their 2025 Annual General Meeting were passed by a poll, reflecting strong shareholder support. This outcome reinforces the company’s strategic direction and commitment to advancing respiratory protection technology, potentially enhancing its position in the industrial and healthcare sectors.

CleanSpace Holdings Highlights FY25 Performance and Strategic Focus
Nov 28, 2025

CleanSpace Holdings Limited presented its FY25 AGM CEO presentation, highlighting the company’s financial performance and strategic direction. The presentation emphasized the company’s commitment to maintaining strong operational performance and its focus on innovation to enhance market positioning. Stakeholders were informed about the company’s adherence to International Financial Reporting Standards and the use of non-IFRS measures to provide a clearer understanding of its financial health.

CleanSpace Holdings Announces Quotation of New Securities on ASX
Nov 7, 2025

CleanSpace Holdings Limited has announced the quotation of 115,200 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code CSX. This move follows the cessation of transfer restrictions on securities previously issued under an employee incentive scheme, potentially enhancing liquidity and market presence for the company.

CleanSpace Holdings Ltd. Announces 2025 AGM and Key Agenda
Oct 28, 2025

CleanSpace Holdings Ltd. has announced its Annual General Meeting (AGM) scheduled for November 28, 2025, where shareholders will review the 2025 Annual Report, including financial, directors’, and auditors’ reports. A key agenda item is the adoption of the Remuneration Report, which will be voted on as a non-binding advisory resolution. The meeting will also address voting exclusions for certain parties, ensuring compliance with the Corporations Act.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 28, 2025